Opioids Switching with Transdermal Systems in Chronic Cancer Pain
<p>Abstract</p> <p>Background</p> <p>Due to tolerance development and adverse side effects, chronic pain patients frequently need to be switched to alternative opioid therapy</p> <p>Objective</p> <p>To assess the efficacy and tolerability of an a...
Main Authors: | Barbarisi M, Sansone P, Pota V, Pace MC, Aurilio C, Grella E, Passavanti MB |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2009-05-01
|
Series: | Journal of Experimental & Clinical Cancer Research |
Online Access: | http://www.jeccr.com/content/28/1/61 |
Similar Items
-
Transdermal opioids for cancer pain
by: Skaer Tracy L
Published: (2006-03-01) -
Pharmacogenetics and its clinical applications in opioid therapy
by: Caterina Aurilio, et al.
Published: (2008-12-01) -
The beneficial use of ultramicronized palmitoylethanolamide as add-on therapy to Tapentadol in the treatment of low back pain: a pilot study comparing prospective and retrospective observational arms
by: Maria Beatrice Passavanti, et al.
Published: (2017-12-01) -
Clinical applications of palmitoylethanolamide in pain management: protocol for a scoping review
by: Maria Beatrice Passavanti, et al.
Published: (2019-01-01) -
Buprenorphine Transdermal System for Opioid Therapy in Patients with Chronic Low Back Pain
by: Allan Gordon, et al.
Published: (2010-01-01)